SUBSCribe
logo
twitterlinkedininstagramUser Profile
search
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • Spotlight Initiatives
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
          • LEADING EDGE
          • SMART ENTERPRISE
        • Accelerating growth: the double-edged sword of self-reliance

          With the world seeking an alternative for China, will India rise to the occasion and indeed be the 'pharmacy to the world'?

          N Mahalakshmi - July 26, 2021
        • Can the country’s manufacturing push be sustained with ‘PLIS’ and thank you?

          With the second wave of Covid-19 pushing the economy into another downward spiral, the burden is now on the PLI scheme to revive growth

          N Mahalakshmi - June 04, 2021
        • PLIS: What’s it got

          Here’s a measure of the scheme’s ambition, account of achievements so far, and a record of brickbats and bouquets 

          June 04, 2021
        • Driven by diligence

          Canara Robeco's Cheenu Gupta believes in knowing her companies inside out, and never being too sure of one’s analysis 

          Anishaa Kumar - March 01, 2021
        • Prescription written in sloppy handwriting? This start-up offers an antidote

          Equipping doctors with digital tools, Farmako aims to build India’s first centralised health record system

          Shailaja Mohapatra - January 14, 2021
        • When the sun shines

          Non-executive director Sudhir Valia sells Sun Pharma stock worth ₹2.91 billion held by Raksha Valia

          Shailaja Mohapatra - January 16, 2021
        • Selling prescription drugs can be a pain. Doceree offers an easy way out

          The pharma-marketing start-up has patented tech to reach the right message to the right doctor 

          Debangana Ghosh - November 04, 2020
        • Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?

          Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh

          V Keshavdev - December 10, 2020
        • “I do not take the market’s view as gospel truth, but I also do not assume it is foolish or stupid”

          ASK Group’s Bharat Shah on why the market is his guidepost when it comes to deciphering tangible price and intangible value

          N Mahalakshmi - October 17, 2020
        • Chronic profit

          Eris Lifesciences promoter Himanshu Shah sells stock worth ₹968 million 

          Shailaja Mohapatra - October 08, 2020